Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $2.0 million.

  • Niagen Bioscience's Prepaid Assets fell 319.66% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 319.66%. This contributed to the annual value of $2.5 million for FY2024, which is 130.61% up from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Prepaid Assets is $2.0 million, which was down 319.66% from $2.1 million recorded in Q2 2025.
  • Niagen Bioscience's 5-year Prepaid Assets high stood at $4.3 million for Q3 2022, and its period low was $972000.0 during Q2 2021.
  • In the last 5 years, Niagen Bioscience's Prepaid Assets had a median value of $2.1 million in 2024 and averaged $2.2 million.
  • Per our database at Business Quant, Niagen Bioscience's Prepaid Assets soared by 14171.4% in 2022 and then plummeted by 4874.38% in 2023.
  • Niagen Bioscience's Prepaid Assets (Quarter) stood at $1.9 million in 2021, then surged by 59.6% to $3.0 million in 2022, then dropped by 17.43% to $2.4 million in 2023, then grew by 1.31% to $2.5 million in 2024, then decreased by 18.25% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.1 million for Q2 2025, and $2.4 million during Q1 2025.